[1] | Fan Y, Xiao W, Li Z, Li X, Chuang PY, Jim B, Zhang W, Wei C, Wang N, Jia W, Xiong H, Lee K, and He JC. RTN1 mediates progression of kidney disease by inducing ER stress. Nat Commun 6: 7841, 2015. (Co-first author, contributed equally to the study.) (IF: 11.470) |
[2] | Xiao W, Fan Y, Wang N, et al. Knockdown of RTN1A attenuates ER stress and kidney injury in albumin overload-induced nephropathy. American Journal of Physiology-Renal Physiology, 2016: ajprenal. 00485.2015. (IF: 3.248) |
[3] | Xiao W, Gui D, Chen T. Effects of Astragaloside IV Protect Against Podocyte Lesion Exposed to High Glucose. Chinese Journal of Integrated Traditional and Western Nephrology, 2013, 5: 008. (IF: 1.217) |
[4] | Fan Y, Li X, Xiao W, et al. BAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic mice. Diabetes, 2015, 64(6): 2220-2233. (IF: 8.095) |
[5] | Fan Y, Wei C, Xiao W, et al. Temporal profile of the renal transcriptome of HIV-1 transgenic mice during disease progression. PloS one, 2014, 9(3): e93019. (IF: 3.234) |
[6] | Gui D, Huang J, Liu W, Guo Y, Xiao W, et al. Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways. Apoptosis, 2013, 18(4): 409-422. (IF: 3.685) |
[7] | Gui D, Huang J, Guo Y, J Chen, Chen Y, Xiao W, et al. Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression. Cytokine, 2013, 61(3): 970-977. (IF: 2.664) |
[8] | Chen T, Zheng L Y, Xiao W, et al. Emodin Ameliorates High Glucose Induced-Podocyte Epithelial-Mesenchymal Transition In-Vitro and In-Vivo. Cellular Physiology and Biochemistry, 2015, 35(4): 1425-1436. (IF: 2.875) |